Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
Go back to Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury| (NASDAQ: EDSA) | Delayed: 6.81 -0.54 (7.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.35 | 52 Week High | $ | |||
| Open | $7.39 | 52 Week Low | $ | |||
| Day High | $7.66 | P/E | N/A | |||
| Day Low | $6.70 | EPS | $ | |||
| Volume | 127,051 | |||||
